申请人:Poxel
公开号:EP2679591A1
公开(公告)日:2014-01-01
The invention relates to compounds that are direct activators of AMPK (AMP-activated protein kinase) and their use in the treatment of disorders regulated by activation of AMPK. For instance, compounds according to the invention are useful for the treatment of diabetes, metabolic syndrome, obesity, liver disease, hepatic steatosis, non alcoholic fatty liver disease (NAFLD), non alcoholic steato-hepatitis (NASH), liver fibrosis, dyslipidemia, hypertriglyceridemia, hypercholesterolemia, inflammation, cancer, cardiovascular diseases, atherosclerosis, high blood pressure, retinopathies or neuropathies.
该发明涉及直接激活AMPK(AMP-激活蛋白激酶)的化合物及其在治疗受AMPK激活调节的疾病中的应用。例如,根据该发明的化合物对于治疗糖尿病、代谢综合征、肥胖、肝病、肝脂肪变性、非酒精性脂肪肝病(NAFLD)、非酒精性脂肪肝炎(NASH)、肝纤维化、血脂异常、高三酰甘油血症、高胆固醇血症、炎症、癌症、心血管疾病、动脉粥样硬化、高血压、视网膜病变或神经病变方面具有用处。